News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement
|Articles|July 17, 2019

Real-World Data: Exploring Possibilities and Overcoming Obstacles

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement

Accelerating Pharma Commercial Strategy with Smarter, Faster, and Bolder AI

ByAvinob Roy
September 4th 2025

Rethinking Market Strategy within a Patient-Centric Era

ByEd Schoonveld,Edward Ahn,Shana Gunderson Hua, PharmD,Rob Philo
July 23rd 2025

How New Policies are Impacting Market Sustainability

ByEd Schoonveld,Edward Ahn,Shana Gunderson Hua, PharmD,Rob Philo
July 21st 2025

The Ins and Outs of Value-Based Contracts: Timing, Evidence, and Risk Alignment

ByEd Schoonveld,Edward Ahn,Shana Gunderson Hua, PharmD,Rob Philo
July 16th 2025

Strategies in Today’s Market for Pricing and Reimbursement Models

ByEd Schoonveld,Edward Ahn,Shana Gunderson Hua, PharmD,Rob Philo
July 14th 2025
Advertisement
Advertisement

Trending on PharmExec

1

The Influence of Targeting CCR5 Receptors

2

Merck to Acquire Cidara for $9.2 Billion

3

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML

4

DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026

5

Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us